Intranasal delivery of a nicotine vaccine candidate induces antibodies in mouse blood and lung mucosal secretions that specifically neutralize nicotine.

Conclusion: Intranasal immunization with a nicotine vaccine candidate can induce systemic and mucosal antibodies that specifically neutralize nicotine. PMID: 32892651 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/32892651?dopt=Abstract

Source: Drug Development and Industrial Pharmacy - September 9, 2020 Category: Drugs & Pharmacology Tags: Drug Dev Ind Pharm Source Type: research